ABSTRACT
cells, an undefined CD11b
Ϫ CD68 Ϫ subset (30%) also 
Introduction
Kupffer cells are liver macrophages that constitute a large population of mononuclear phagocytes in the body. The major function of Kupffer cells is to clear pathogens, such as microorganisms, immune complexes, endotoxins, portal antigens, and tumor cells [1] [2] [3] [4] . Bacterial clearance in the liver, particularly by Kupffer cells, is crucial for host defense against bacteremia [5] , as 70 -80% of the bacteria that enter the bloodstream accumulate in the liver and are removed by these cells and also by phagocytic B cells [2, 6 -8] . Kupffer cells also produce a variety of proinflammatory cytokines (IL-12, IL-1, IL-18, TNF, etc.) and superoxide/ROS after the phagocytosis of pathogens and present antigens to T cells and other lymphocytes (including NK cells and NKT cells) [1, 2] . Cytokines produced by Kupffer cells, such as IL-6 and TNF, induce the production of acute-phase proteins and complement components by hepatocytes, which together with Ig, are crucial for the opsonization and phagocytosis of bacteria by Kupffer cells [1, 6] . We reported previously that murine liver F4/80 ϩ Kupffer cells/macrophages could be classified into two subsets, cytokine-producing CD11b ϩ cells and phagocytic and ROS-producing CD68 ϩ cells [2, 9] . In normal mice, F4/80 ϩ Kupffer cells are mainly CD68 ϩ , which are different from macrophages in other tissues or in the systemic circulation, which are primarily CD11b ϩ [2, 9] . The CD68 ϩ cells may preferentially adhere to liver sinusoidal endothelial cells or hepatocytes (fixed or resident Kupffer cells) relative to CD11b ϩ cells, as suggested by their increased proportion and number following collagenase treatment of the liver specimens [2, 9] . Klein et al. [10] demonstrated mouse Kupffer cell heterogeneity in terms of two groups, bone marrow-derived macrophages and sessile hepatic ones. The former group appears to be CD11b ϩ cells, and the latter group consists of CD68 ϩ cells [9, 10] . Holt et al. [11] also indicated that [9, 12] . In this view point, we reported in Con A-induced hepatitis that the TNF produced by CD11b ϩ cells is required for the activation and ROS production of CD68 ϩ cells and that ROS-producing CD68 ϩ cells are the final effector for hepatocyte injury in this hepatitis [13] . On the other hand, we have also reported that hepatic injury induced by ␣-galactosylceramide [14] or bacterial DNA (CpG-ODN) [15] is mediated by FasL-expressing NKT cells activated by TNF produced by CD11b Kupffer cells. In addition, when mice are fed a high-fat and high-cholesterol diet, the CD68 ϩ cells decreased, but the CD11b ϩ cells increase in number, and the increased TNF produced by CD11b ϩ cells rendered the mice susceptible to apoptotic hepatic injury induced by FasLexpressing NKT cells [16] .
However, in addition to these two types of Kupffer cells, a substantial population of CD11b Ϫ CD68 Ϫ cells still exists in the F4/80 ϩ cells. The Fc␥R (CD16/CD32) antibody was identified first by the observation that IgG antibodies could be directly cytophilic for macrophages [17, 18] . The C-reactive protein enhances the phagocytosis of Kupffer cells but decreases their TNF production via the Fc␥RII (CD32) [19, 20] . In addition, a CRIg, which is highly expressed on Kupffer cells, has been identified recently [21] . CRIg is required for efficient complement-mediated phagocytosis of Kupffer cells [21] .
We herein sought to accomplish a more comprehensive subclassification of mouse F4/80 ϩ Kupffer cells, as well as human CD14 ϩ Kupffer cells, using CD11b, CD68, and the CD32 (Fc␥RII) antibody. F4/80 is a representative surface marker for mouse mononuclear phagocytes but not for human cells. CD14, which is known as a PRR, was demonstrated to participate in phagocytosis by macrophages and was also recognized to be a molecule involved in transducing LPS signals [22, 23] . We therefore used CD14 to define Kupffer cells in humans. Based on these findings, we demonstrate the more fundamental and developmental subclassification of murine and human Kupffer cells, which also provides the first definition of the distinct immunological functions of resident Kupffer cells and recruited Kupffer cells/macrophages in the host: bactericidal activity and antitumor activity.
MATERIALS AND METHODS

Mice and reagents
Male, 7-week-old C57BL/6 mice were purchased from CLEA Japan (Tokyo, Japan). S. aureus 209P (ATCC 6538P) was used from our laboratory collection.
Human liver tissues
Liver tissue specimens from nine patients (age range, 64 -72 years; six males and three females) were obtained from surgically resected liver tissues after obtaining the informed consent of each patient and the approval of the Institutional Review Board at the National Defense Medical College (Saitama, Japan). Three of these patients had obstructive jaundice and were excluded, because liver MNCs were difficult to obtain; obstructive jaundice may make it difficult to isolate MNCs from the liver specimens. Of the other six cases without preoperative jaundice, one had intrahepatic bile duct stones, two had hepatocellular carcinoma, two had metastatic carcinoma, and one had intrahepatic cholangiocarcinoma; all six were included in the analysis.
Isolation of MNCs, including Kupffer cells
Under the approval of the Institutional Review Board at the National Defense Medical College, human liver cells were obtained from surgical specimens. The murine livers were removed under deep anesthesia. The liver nonparenchymal MNCs were isolated, as reported previously [10, 12, 13, 24, 25] . The human and murine liver tissues were minced with scissors. After adding 15 ml HBSS containing 0.05% collagenase (Wako, Osaka, Japan), specimens were shaken for 20 min at 37°C. Then, the liver specimen was filtered through a stainless-steel mesh, suspended in isotonic 33% Percoll solution containing 10 U/ml heparin, and centrifuged for 20 min at 500 g at room temperature. After lysing the red blood cells, the remaining cells were washed twice in RPMI 1640 containing 10% FBS [12, 13] .
Flow cytometric analysis
Before staining with antibodies (except for CD16/CD32), the murine liver MNCs were incubated with Fc-blocker (2.4 G2; BD PharMingen, San Diego, CA, USA) to prevent any nonspecific binding. The MNCs were stained using a PE-Cy5-conjugated anti-F4/80 antibodies (BM8; eBioscience, San Diego, CA, USA), PE-conjugated anti-CD11b antibodies (M1/70; eBioscience), PE-conjugated anti-CD16/CD32 antibodies (93; eBioscience), or biotin-conjugated anti-CD68 antibodies (FA-11: AbD Serotec, Oxford, UK) with PE-streptavidin. For the characterization of Kupffer cells, the MNCs were stained with a FITC-conjugated anti-c-kit (CD117) antibodies (2B8; eBioscience), biotinylated anti-MerTK antibodies (BAF591; R&D Systems, Minneapolis, MN, USA), or PE-conjugated anti-Fc␥RI (CD64) antibodies (X54-5/7.1; BD Biosciences, San Jose, CA, USA). Human liver MNCs were similarly stained with a PE-Cy7-conjugated anti-CD14 antibody (RMO52; Beckman Coulter, Miami, FL, USA), PE-Cy5-conjugated anti-CD11b antibody (Bear 1; Beckman Coulter), PE-conjugated anti-CD68 antibody (Y1/ 82A; eBioscience), or PE-conjugated anti-CD32 antibody (2E1; Immunotech, Marseille, France). Flow cytometry was performed using an FC500 instrument (Beckman Coulter).
Cell sorting
For the PCR analysis, CD11b positively sorted cells were enriched by positive selection using a MACS system (Miltenyi Biotec, Bergisch Gladbach, Germany). CD32 positively sorted cells and CD68 positively sorted cells were obtained in the same way.
RNA extraction, reverse transcription, and quantitative PCR Immunohistochemistry
Fresh, frozen sections of the liver were cut 6 m-thick on a cryostat, collected on slides, and dried immediately. The sections were fixed with acetone and washed. After incubation with 1% Block Ace (DS Pharma Biomedical, Tokyo, Japan) for 10 min, the slides were incubated overnight with anti-CD68 antibodies (FA-11), anti-CD11b antibodies (M1/70), or anti-CD16/32 antibodies (93), diluted 1:100, followed by incubation with Histofine Simple Stain Mouse MAX-PO (rat; Nichirei, Tokyo, Japan) for 1 h and Histogreen (Abcysonline, Paris, France) for 5 min.
Evaluation of FITC-Escherichia coli or FITC-S. aureus phagocytosis
For the in vivo assessment of phagocytosis, the murine livers were removed 5 min after FITC-labeled E. coli or FITC-labeled S. aureus (BioParticles; Invitrogen Life Technologies) injection, and their MNCs were isolated and examined by flow cytometry.
Determination of phagolysosome formation
Liver MNCs (5ϫ10 5 cells/200 l) were incubated with 20 l pHrodo-conjugated E.coli (BioParticles; Invitrogen Life Technologies), which detected a decrease of the pH in phagolysosomes by fluorescent emission after the incubation with E.coli for 30 min at 37°C in 5% CO 2 .
Depletion of resident Kupffer cells
Clodronate (LKT Laboratories, St. Paul, MN, USA) was encapsulated into liposomes, and 100 l of a 25-mg/ml suspension was injected i.p. into mice, 36 h before the experiments, to deplete the resident CD32/68 Kupffer cells.
Susceptibility to S. aureus infection
The survival rates of clodronate-pretreated and control mice infected with a sublethal dose (3ϫ10 8 CFU) of S. aureus were determined following injection of the bacteria into the lateral tail vein.
Determination of the bacterial burden
At various time-points after infection with 3 ϫ 10 8 CFU of S. aureus, organs were harvested and homogenized in PBS. The blood, as well as homogenates from the organs, was serially diluted tenfold in PBS, spread on brainheart infusion agar, and incubated for 12 h at 37°C. The average number of bacteria in the homogenates was determined by including the colony counts across the serial dilutions to obtain a single reportable value for each organ.
MCP-1 production by MNCs from control and clodronate-treated mice against S. aureus
Clodronate-pretreated and control mice were infected with 1 ϫ 10 8 CFU of S. aureus. The serum was collected from the orbital vein of each mouse at the indicated time-points after the infection. Liver MNCs (5ϫ10 5 cells/200 l), isolated from control or clodronate-treated mice, were cocultured with 1 ϫ 10 7 CFU of S. aureus at 37°C in 5% CO 2 in a 96-well plate. The supernatants in the wells of the plates incubated for the indicated times were collected to measure the levels of MCP-1 using ELISA kits for mouse MCP-1 (BD Biosciences).
Survival after injection of metastatic EL-4 cells
EL-4 cells of C57BL/6 origin were used for the metastasis experiments. The spleens of mice, which were pretreated with clodronate or saline (control), were exposed to allow for an intrasplenic injection of 1 ϫ 10 6 EL-4 tumor cells. This approach results in the metastasis of EL-4 cells almost exclusively to the liver [26] . In addition, the liver was removed 20 days after the intrasplenic injection of EL-4 cells. The number of metastatic foci on the liver surface was measured.
Cytotoxity, IL-12, and IFN-␥ production of liver MNCs from control and clodronate-treated mice against EL-4 tumor cells
The target tumor cells were labeled with 10 g/mL calcein-AM (Kohjin Bio, Saitama, Japan) and then were cocultured at 37°C in 5% CO 2 in a 96-well plate for 4 h with liver MNCs (5ϫ10 5 cells/200 l), isolated from control or clodronate-pretreated mice. The E:T ratios were 25:1, 50:1, and 100:1. The plate was placed on the microscope stage of the Terascan instrument to assess the cytotoxicity (Mineva Tech, Tokyo, Japan). The supernatants in the wells of the plates incubated for 4 h at an E:T ratio of 100:1 were collected to measure the levels of IL-12 and IFN-␥ using ELISA kits for mouse total IL-12 (Pierce Biotechnology, Woburn, MA, USA) and IFN-␥ (BD Biosciences).
IL-6, IL-1␣, and TNF-␣ production by MNCs from control and clodronate-treated mice against S. aureus and EL-4 tumor cells
Liver MNCs (5ϫ10 5 cells/200 l), isolated from control or clodronatetreated mice, were cocultured with 1 ϫ 10 7 CFU of S. aureus or EL-4 cells at an E:T ratio of 100:1 at 37°C in 5% CO 2 in a 96-well plate. The supernatants in the wells of the plates incubated for 4 h were collected to measure the levels of IL-6, IL-1␣, and TNF-␣ using ELISA kits for mouse IL-6 and TNF-␣ (BD Biosciences) and IL-1␣ (Pierce Endogen, Rockford, IL, USA).
Statistical analysis
For each experiment, the results were expressed as the mean values Ϯ se. The statistical analyses were performed using the SAS software program, version 9.2 (SAS Institute, Cary, NC, USA). Where appropriate, Student's t-test was used to compare the data from two different groups. The Wilcoxon rank sum test was applied in the survival studies. P Ͻ 0.05 was considered statistically significant.
RESULTS
Subclassification of mouse liver F4/80 ؉ Kupffer cells/macrophages
Approximately one-fourth of the liver MNCs in the normal, steady-state liver are F4/80 ϩ Kupffer cells/macrophages (Fig. 1A, left) . Only a few Gr-1 ϩ granulocytes are present (3%; Fig. 1A , left). Granulocytes highly express Gr-1 and CD11b ( (Fig. 1B) , most Kupffer cells can be identified by these staining methods. A schematic diagram of the distribution of the three subjects of F4/80
ϩ Kupffer cells/ macrophages is shown (Fig. 1C) .
In contrast to peripheral blood F4/80 ϩ CD11b ϩ monocytes, highly expressing CD115 (M-CSFR), most liver or spleen F4/ 80 ϩ CD11b ϩ macrophages do not express CD115 (Supplemental Fig. 1C ), thus implying that CD11b ϩ monocytes may lose CD115 after migration to organs/tissues.
mRNA expression of the CRIg in spleen MNCs, liver MNCs, and sorted liver MNCs
Whole liver MNCs expressed CRIg mRNA, whereas whole spleen MNCs did not show any CRIg mRNA (Fig. 1D) . Among the liver MNCs, the sorted CD68 ϩ cells and sorted CD32 ϩ cells showed the expression of CRIg mRNA, whereas CRIg mRNA was not detected in the sorted CD11b ϩ cells, as the expression level was lower than the limit of detection of the instrument (Fig. 1D ). The results are described as the fold expression relative to the expression of F4/80 mRNA in the same sample. Consistent with the above results (Fig. 1D) , the spleen F4/80 ϩ cells and peripheral blood F4/80 ϩ cells contained few CD68 ϩ cells and no CD32 ϩ cells ( Fig. 2A and B) .
Immunohistochemical staining of CD32
؉ , CD68
؉ , and CD11b
؉ cells CD32 ϩ and CD68 ϩ cells were stellate or spindle-shaped and were located along the sinusoids (Fig. 3A and C) . CD11b ϩ cells were round or oval and were fewer in number than CD32 ϩ and CD68 ϩ cells (Fig. 3B ).
CD32
؉ cells and CD68 ؉ cells are distinct from CD11b ؉ cells
The FS (cell size) and side-scatter (intracellular components and structure) analyses revealed that the distributions of CD32 ϩ cells and CD68 ϩ cells are broad and almost the same, whereas they are different from CD11b ϩ cells and liver granulocytes (Supplemental Fig. 2A  and B ). In addition, the FS analysis revealed that CD68 ϩ cells and CD32 ϩ cells are larger in size than CD11b ϩ cells, showing 481 Ϯ 13, 466 Ϯ 7, and 425 Ϯ 5 (PϽ0.01 vs. the others) as the mean FS values Ϯ se, respectively (nϭ4 or 5). Furthermore, 6 days after the treatment of mice with 6 Gy irradiation, the CD11b ϩ cells disappeared almost completely, but the CD32 ϩ and CD68 ϩ cells were present in the liver (Fig. 4B) . The CD11b ϩ macrophages also largely disappeared in the spleen, bone marrow, and PBMCs (data not shown), and transfer of bone marrow cells into irradiated mice did induce/reconstitute the liver CD11b cells within a week (data not shown 
Phagocytic activities and functional phagolysosomal formation of F4/80
؉ cell fractions in mice
In vivo administration of FITC-E. coli or FITC-S. aureus demonstrated that CD68 ϩ or CD32 ϩ Kupffer cells phagocytosed more bacteria than did CD11b ϩ Kupffer cells/macrophages ( Fig. 5A and B) . When liver MNCs were incubated with pHrodo-conjugated E. coli at an E. coli:cell ratio of 20:1 to detect a decrease in the pH in phagolysosomes by fluorescence emission after the ingestion of E. coli, the CD11b ϩ cells did not show any functional phagolysosomes, as indicated by the lack of staining with pHrodo-conjugated E. coli (Fig. 5C ). In contrast, CD68 ϩ cells showed substantial phagolysosomal formation (18.5%), whereas CD32
ϩ cells had only a small amount of positive cells (4.9%; Fig. 5C The proportion of liver F4/80 ϩ CD68 ϩ cells increased, whereas that of F4/80 ϩ CD32 ϩ cells decreased immediately (5 min) in the liver after E. coli or S. aureus injection (Supplemental Fig. 3) . The mean fluorescence intensity of CD32 expression decreased significantly after bacterial injection (Supplemental Fig. 3 ), thus suggesting that CD32 ϩ Kupffer cells acquire CD68 but lose CD32 after engulfment of bacteria. Furthermore, consistent with the above hypothesis, approximately one-half of the CD32
ϩ Kupffer cells expressed c-kit (CD117, a marker expressed by premature precursor cells), whereas virtually no CD11b ϩ cells expressed c-kit (Fig. 6A) . Approximately two-thirds of the CD32 ϩ CD68 Ϫ cells expressed c-kit, 18% of CD32 ϩ CD68 ϩ cells expressed c-kit, and only a few CD32 Ϫ CD68 ϩ cells expressed c-kit (2.5%; Fig. 6B ). CD34 expression was associated with the same pattern of c-kit expression (data not shown). In addition, 24% of CD32 Ϫ CD68 ϩ cells, but not the other two subsets, expressed CD11c, presumably as an activation/maturation marker (Fig. 6B) . (Fig. 6C) . Spleen F4/80 ϩ CD11b Ϫ cells also expressed these molecules as resident tissue macrophages (Supplemental Fig. 4) 
Clodronate-pretreated mice do not have resistance to S. aureus infection but exhibit increased resistance to liver EL-4 tumor metastases
CD32/CD68 cells were depleted from the liver MNCs in clodronate-treated mice (Fig. 4C) , and immunohistochemical staining of liver sections also confirmed that spindle-shaped CD68 cells (but not round or oval CD11b cells) greatly re- duced after clodronate treatment (data not shown and unpublished results). Clodronate-treated mice became highly susceptible to S. aureus infection. All such mice died within 2 days after infection (Fig. 7A) . The depletion of CD32/CD68 cells with clodronate decreased the bacterial counts in the liver but conversely, suppressed the clearance of circulating bacteria significantly in the blood, 20 min after i.v. injection of S. aureus (Fig. 7B) and thereafter, resulted in a higher level of bacteria in the spleen (Fig. 7C) . These results, regarding S. aureus infection in clodronate-treated mice, are consistent with the results in CRIg-deficient mice [21] . In addition, the depletion of CD32/CD68 cells with clodronate suppressed the MCP-1 levels significantly in the sera after S. aureus administration to mice (Fig. 7D) . Liver MNCs depleted of CD32/CD68 cells (CD11b ϩ cells) also did not produce MCP-1 in vitro after culture with S. aureus (Fig. 7E) , whereas these cells produced IL-6, IL-1␣, and TNF-␣ in vitro (Fig. 7F-H) . Therefore, CD32/ CD68 cells were identified as the MCP-1 chemokine producers, and CD11b cells are main cytokine producers.
However, it was surprising that clodronate-treated mice survived longer than control mice after an intrasplenic injection of EL-4 tumor cells (liver tumor metastasis model; Fig. 8A ). The number of metastatic foci on the liver surface, 20 days after the intrasplenic injection, was smaller in the clodronatetreated mice than that in control mice (6.5Ϯ1.3 and 20.8Ϯ6.1, respectively; Fig. 8B and Fig. 9 ). The cytotoxic activity of liver MNCs in the clodronate-treated mice against EL-4 tumor cells was higher than that of cells from control mice (Fig. 8C) . In addition, the liver MNCs from clodronate-treated mice cultured with EL-4 cells in vitro produced more IL-12 and TNF-␣ (mainly from CD11b Kupffer cells/macrophages) and IFN-␥ (mainly from NK/NKT cells) than did liver MNCs from control mice (Fig. 8D, E, and H) , presumably because the depletion of CD32/CD68 cells not only increased the proportion/ number of CD11b cells but also functionally activated the CD11b cells, as reported by our previous study [9] and suggested further by their acquisition of surface CD68 expression (Fig. 4C ) and increased size, revealed by a FS flow cytometric analysis (data not shown). However, the amounts of IL-6 and IL-1␣ produced in response to EL-4 tumor cells were small and did not differ significantly between control liver MNCs and liver MNCs depleted of CD32/CD68 Kupffer cells (Fig. 8F and  G) . Although the precise mechanism(s) underlying these effects is unknown at present, it is possible that apoptosis/death of CD32/CD68 Kupffer cells by clodronate may induce an inflammatory condition in the liver by producing MCP-1, and thereby, CD11b cells increased. It is also possible that increased CD11b cells in the liver may compensate the function of CD68 cells. It should be noted that the nonadherent liver MNCs alone (without CD11b cells) did not show any cytotoxicity against tumor cells (data not shown). These findings suggest that as we reported previously [1, 2] , the IL-12 produced by CD11b cells is required for the antitumor cytotoxicity of liver NK/NKT cells.
Human liver CD14
؉ Kupffer cell/macrophage subclassification and phagocytic activities
ϩ cells from surgical specimens were examined by CD11b, CD68, and CD32. The CD14
ϩ Kupffer cells comprised ϳ10% of the human liver MNCs. Although the proportion of Kupffer cells in the human liver MNCs was lower than that in the murine liver (10% vs. 20%), this may be because the human liver contains a larger amount of blood, and it may be more difficult to harvest human Kupffer cells by collagenase treatment than it is from the mouse liver. Nevertheless, similar to mice, the human CD14
ϩ Kupffer cells were subdivided into three subsets: (Fig. 10A) . Human CD14 ϩ cells in the peripheral blood were also CD11b ϩ CD68 Ϫ , similar to the mouse spleen MNCs and PBMCs, but a substantial population of cells (33%) was CD11b ϩ CD32 ϩ (Fig. 10B) . These results suggest that CD11b Ϫ CD32/CD68 ϩ cells might be resident liver Kupffer cells in humans as well as in mice. Consistently with the above findings, in vitro incubation of pHrodo E. coli with human liver MNCs also demonstrated that CD11b Ϫ (CD32/CD68 ϩ ) Kupffer cells had vigorous activities with regard to phagolysosomal formation (51.4%), whereas CD11b ϩ Kupffer cells/macrophages did not (3.5%; Fig. 10C ).
DISCUSSION
Macrophage/monocyte lineage cells have been considered to have heterogeneity as a result of the specialization of tissue macrophages under the influence of their respective microenvironments [29, 30] . Kupffer cells may have to develop unique characteristics based on their specific anatomical and physiological microenvironment.
In the present study, we showed that murine F4/80 ϩ and human CD14 phagolysosomal formation in vivo, as well as in vitro, which is consistent with their capacity to produce ROS [9] . CD68 has been suggested to be involved in membrane fusion or antigen processing [31] [32] [33] . These characteristics of CD68 ϩ Kupffer cells may be related to their potent phagocytic and bactericidal activity. The population of CD68 ϩ CD32 Ϫ cells increased, and that of CD68 Ϫ CD32 ϩ cells decreased immediately after the administration of FITC-E. coli or -S. aureus. Most CD32 ϩ Kupffer cells, but not CD68 ϩ Kupffer cells, expressed c-kit (CD117) and CD34, which are markers of immature precursors. These findings indicate that CD32
ϩ Kupffer cells are precursors of CD68
ϩ Kupffer cells and suggest that CD32/CD68 Kupffer cells have a high capacity for reproduction within the liver. As even adult mouse liver contains c-kit ϩ hematopoietic stem cells [34, 35] , it raises the possibility that c-kit ϩ CD32
ϩ Kupffer cells may be derived from not only yolk sac and fetal liver [36, 37] but also from adult liver hematopoietic stem cells, independent of monocytes and CD11b ϩ macrophages. In addition, CD32/CD68 Kupffer cells may acquire CD11c during their maturation process.
Furthermore, the CD32/CD68 Kupffer cells expressed MerTK (a kinase involved in efferocytosis) and CD64 (Fc␥RI) as resident tissue-macrophage markers, but liver F4/80
Ϫ
CD11c
ϩ cells (presumably DCs) did not express these molecules. Therefore, consistent with a recent study [27] that the liver CD32/CD68 cells might play a pivotal role not only in phagocytosis and the retention of bacteria in the liver but also in the elimination of bacteria systemically. Thus, liver CD32/CD68 Kupffer cells are essential effectors to prevent sepsis/bacteremia. These findings might be consistent with the fact that C-reactive proteins could rescue lethally infected mice via the Fc␥RII (CD32) of Kupffer cells [19, 20] . Although spleen-resident macrophages (CD11b Ϫ F4/80 ϩ cells) expressed MerTK and CD64, they lacked CD32, CD68, and CRIg. Therefore, resident liver CD32/CD68 Kupffer cells are different from resident spleen macrophages. However, resident macrophages in the spleen, peritoneal cavity, and adipose tissues, etc., may also play an important role in the bacterial clearance in each tissue.
It should be noted that CD68
ϩ Kupffer cells, but not CD11b ϩ cells, produced MCP-1, a chemokine that is a major ligand for CCR2, upon activation. It was reported previously that CCR2-deficient mice showed a dramatic reduction in macrophage accumulation in the peritoneal cavity and liver upon exposure to inflammatory stimuli [38, 39] . CD68
ϩ Kupffer cells produce MCP-1 upon activation to induce the accumulation of CD11b ϩ macrophages from the circulation or bone marrow. Such recruited CD11b ϩ macrophages may produce cytokines (IL-12, TNF, etc.) and may collaborate with CD68 ϩ Kupffer cells and neutrophils in various types of liver inflammation.
We reported previously that CD11b ϩ cells did not produce ROS even after E. coli infection/phagocytosis, implying that they Control (n=10)
Clod. ip (n=9) [days] [%] might not have efficient bacteriolytic activity [9] . Consistently, the results of the current study with pHrodo-E. coli also suggested that CD11b ϩ cells, in contrast to CD68 ϩ cells, did not show functional phagolysosomal formation, indicating that they cannot kill bacteria effectively. Depletion of resident Kupffer (CD32/ CD68 ϩ ) cells with clodronate made mice highly susceptible to S. aureus infection but interestingly, decreased the liver metastases in EL-4-injected mice and improved the survival of these mice. These results suggest that resident CD68 ϩ cells may not be involved directly in antitumor immunity, and recruited CD11b ϩ cells may play a pivotal role in antitumor immunity by producing cytokines (e.g., IL-12), as we reported recently [40] . It should be noted that although the lung normally has no NKT cells, NKT cells appear after IL-12 injection, and adoptive transfer of IL-12-activated NKT cells inhibits hematogenous tumor metastases in the lung and kidney [1] , suggesting that recruited liver CD11b ϩ cells may also play a pivotal role in systemic antitumor immunity by providing activated NK/NKT cells to other organs.
Notably, we reported previously that when mice are fed a highfat and high-cholesterol diet, the CD11b ϩ cells increase in number, and their IL-12 production and the antitumor activity of liver NK/NKT cells increase [40] . However, the increased TNF produced by CD11b ϩ cells rendered the mice susceptible to LPSinduced shock [40] . It is also worth noting that when mice receive a burn injury, the number of CD11b ϩ cells increases gradually, but the CD68 injury, which renders the mice highly susceptible to bacterial infection as a result of increased TNF production and decreased phagocytosis and bactericidal activity [41, 42] . In addition, IL-18 therapy after burn injury inhibits the decrease of CD68 ϩ Kupffer cells and enhances their phagocytic activity by increasing the amount of IFN-␥ produced by NK cells [41, 42] . Therefore, both types of liver Kupffer cells/macrophages may normally act against infections and tumors synergistically but sometimes show different profiles, depending on the immune conditions.
Human liver CD14 ϩ Kupffer cells were also subdivided into a CD11b ϩ subset, CD68 ϩ subset, and CD32 ϩ subset, and the CD68 ϩ cells and CD32 ϩ cells overlapped in humans as well as in mice. Human CD68 ϩ and/or CD32 ϩ Kupffer cells, but not CD11b ϩ Kupffer cells/macrophages, may have an efficient bactericidal activity, as suggested by the staining of pHrodo-E. coli. Thus, the essential characteristics of mouse Kupffer cells might also be applicable to human Kupffer cells.
We reported previously that mouse liver B cells produced IL-12 and IFN-␥ but produced little IgM upon LPS activation, whereas spleen B cells produced a large amount of IgM but did not produce these cytokines [43] . In addition, LPS-activated hepatic B cells stimulated NK cells directly and indirectly (via IL-12 production) to produce IFN-␥ [43] . Furthermore, we have demonstrated recently that not only liver B-1 cells but also B-2 cells show phagocytic and bactericidal activity against E. coli. Such E. coli phagocytic liver B-2 cells also produce IL-12, whereas spleen B-2 cells phagocytose E. coli but cannot kill the bacteria [7, 8] . Instead, spleen B-2 cells produce IgM [2, 7, 8] . These results suggest that besides Kupffer cells, NK cells, and NKT cells, B cells are also involved in cellular immunity and the innate immunity of the liver and that macrophages and B-2 cells are subclassified into two subsets: phagocytic cells and producing cells (cytokines, IgM).
In conclusion, mouse and human liver Kupffer cells/macrophages can be subclassified comprehensively into resident CD32 
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